Cargando…

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients

BACKGROUND: Many intracranial meningioma patients have an impaired health-related quality of life (HRQoL) and neurocognitive functioning up to 4 yr after intervention. OBJECTIVE: To assess the long-term (≥5 yr) disease burden of meningioma patients. METHODS: In this multicenter cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamanipoor Najafabadi, Amir H, van der Meer, Pim B, Boele, Florien W, Taphoorn, Martin J B, Klein, Martin, Peerdeman, Saskia M, van Furth, Wouter R, Dirven, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735868/
https://www.ncbi.nlm.nih.gov/pubmed/32818258
http://dx.doi.org/10.1093/neuros/nyaa351
_version_ 1783622719101730816
author Zamanipoor Najafabadi, Amir H
van der Meer, Pim B
Boele, Florien W
Taphoorn, Martin J B
Klein, Martin
Peerdeman, Saskia M
van Furth, Wouter R
Dirven, Linda
author_facet Zamanipoor Najafabadi, Amir H
van der Meer, Pim B
Boele, Florien W
Taphoorn, Martin J B
Klein, Martin
Peerdeman, Saskia M
van Furth, Wouter R
Dirven, Linda
author_sort Zamanipoor Najafabadi, Amir H
collection PubMed
description BACKGROUND: Many intracranial meningioma patients have an impaired health-related quality of life (HRQoL) and neurocognitive functioning up to 4 yr after intervention. OBJECTIVE: To assess the long-term (≥5 yr) disease burden of meningioma patients. METHODS: In this multicenter cross-sectional study, patients ≥5 yr after intervention (including active magnetic resonance imaging (MRI) surveillance) were included and assessed for HRQoL (Short-Form Health Survey 36), neurocognitive functioning (neuropsychological assessment), anxiety and depression (Hospital Anxiety and Depression Scale), and work productivity (Short Form-Health and Labour Questionnaire). Multivariable and propensity score regression analyses were used to compare patients and controls, and different treatment strategies corrected for possible confounders. Clinically relevant differences were reported. RESULTS: At a median of 9 yr follow-up after intervention, meningioma patients (n = 190) reported more limitations due to physical (difference 12.5 points, P = .008) and emotional (13.3 points, P = .002) health problems compared with controls. Patients also had an increased risk to suffer from anxiety (odds ratio [OR]: 2.6, 95% CI: 1.2-5.7) and depression (OR: 3.7, 95% CI: 1.3-10.5). Neurocognitive deficits were found in 43% of patients. Although postoperative complications, radiotherapy, and reresection were associated with worse verbal memory, attention, and executive functioning when compared to patients resected once, the only clinically relevant association was between reresection and worse attention (–2.11, 95% CI: –3.52 to –0.07). Patients of working age less often had a paid job (48%) compared with the working-age Dutch population (72%) and reported more obstacles at work compared with controls. CONCLUSION: In the long term, a large proportion of meningioma patients have impaired HRQoL, neurocognitive deficits, and high levels of anxiety or depression. Patients treated with 1 resection have the best neurocognitive functioning.
format Online
Article
Text
id pubmed-7735868
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77358682020-12-17 Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients Zamanipoor Najafabadi, Amir H van der Meer, Pim B Boele, Florien W Taphoorn, Martin J B Klein, Martin Peerdeman, Saskia M van Furth, Wouter R Dirven, Linda Neurosurgery Research—Human—Clinical Studies BACKGROUND: Many intracranial meningioma patients have an impaired health-related quality of life (HRQoL) and neurocognitive functioning up to 4 yr after intervention. OBJECTIVE: To assess the long-term (≥5 yr) disease burden of meningioma patients. METHODS: In this multicenter cross-sectional study, patients ≥5 yr after intervention (including active magnetic resonance imaging (MRI) surveillance) were included and assessed for HRQoL (Short-Form Health Survey 36), neurocognitive functioning (neuropsychological assessment), anxiety and depression (Hospital Anxiety and Depression Scale), and work productivity (Short Form-Health and Labour Questionnaire). Multivariable and propensity score regression analyses were used to compare patients and controls, and different treatment strategies corrected for possible confounders. Clinically relevant differences were reported. RESULTS: At a median of 9 yr follow-up after intervention, meningioma patients (n = 190) reported more limitations due to physical (difference 12.5 points, P = .008) and emotional (13.3 points, P = .002) health problems compared with controls. Patients also had an increased risk to suffer from anxiety (odds ratio [OR]: 2.6, 95% CI: 1.2-5.7) and depression (OR: 3.7, 95% CI: 1.3-10.5). Neurocognitive deficits were found in 43% of patients. Although postoperative complications, radiotherapy, and reresection were associated with worse verbal memory, attention, and executive functioning when compared to patients resected once, the only clinically relevant association was between reresection and worse attention (–2.11, 95% CI: –3.52 to –0.07). Patients of working age less often had a paid job (48%) compared with the working-age Dutch population (72%) and reported more obstacles at work compared with controls. CONCLUSION: In the long term, a large proportion of meningioma patients have impaired HRQoL, neurocognitive deficits, and high levels of anxiety or depression. Patients treated with 1 resection have the best neurocognitive functioning. Oxford University Press 2020-08-20 /pmc/articles/PMC7735868/ /pubmed/32818258 http://dx.doi.org/10.1093/neuros/nyaa351 Text en © Congress of Neurological Surgeons 2020. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research—Human—Clinical Studies
Zamanipoor Najafabadi, Amir H
van der Meer, Pim B
Boele, Florien W
Taphoorn, Martin J B
Klein, Martin
Peerdeman, Saskia M
van Furth, Wouter R
Dirven, Linda
Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
title Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
title_full Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
title_fullStr Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
title_full_unstemmed Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
title_short Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
title_sort long-term disease burden and survivorship issues after surgery and radiotherapy of intracranial meningioma patients
topic Research—Human—Clinical Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735868/
https://www.ncbi.nlm.nih.gov/pubmed/32818258
http://dx.doi.org/10.1093/neuros/nyaa351
work_keys_str_mv AT zamanipoornajafabadiamirh longtermdiseaseburdenandsurvivorshipissuesaftersurgeryandradiotherapyofintracranialmeningiomapatients
AT vandermeerpimb longtermdiseaseburdenandsurvivorshipissuesaftersurgeryandradiotherapyofintracranialmeningiomapatients
AT boeleflorienw longtermdiseaseburdenandsurvivorshipissuesaftersurgeryandradiotherapyofintracranialmeningiomapatients
AT taphoornmartinjb longtermdiseaseburdenandsurvivorshipissuesaftersurgeryandradiotherapyofintracranialmeningiomapatients
AT kleinmartin longtermdiseaseburdenandsurvivorshipissuesaftersurgeryandradiotherapyofintracranialmeningiomapatients
AT peerdemansaskiam longtermdiseaseburdenandsurvivorshipissuesaftersurgeryandradiotherapyofintracranialmeningiomapatients
AT vanfurthwouterr longtermdiseaseburdenandsurvivorshipissuesaftersurgeryandradiotherapyofintracranialmeningiomapatients
AT dirvenlinda longtermdiseaseburdenandsurvivorshipissuesaftersurgeryandradiotherapyofintracranialmeningiomapatients
AT longtermdiseaseburdenandsurvivorshipissuesaftersurgeryandradiotherapyofintracranialmeningiomapatients